Evidence map›Paper›PMID 41332821›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Differences in prognostic value of

Claudio A Mosse, Michele LeNoue-Newton, Julie A Lynch, Amy M Perkins, Fern Fitzhenry, Kathryn M Pridgen, Freneka Minter, Mia Levy, Michael E Matheny

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Claudio A MosseDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Michele LeNoue-NewtonVanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Julie A LynchVA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA.ORCID 0000-0003-0108-2127
Amy M PerkinsDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Fern FitzhenryVanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Kathryn M PridgenVA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA.
Freneka MinterDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Mia LevyFoundation Medicine, Cambridge, MA, USA.
Michael E MathenyGeriatric Research Education and Clinical Care Service & VETWISE-LHS COIN, Tennessee Valley Healthcare System (TVHS) VA Medical Center, Veterans Health Administration, Nashville, TN, USA.ORCID 0000-0003-3217-4147

Funding

Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial NetworkU01HG010232 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CAVANAUGH, KERRI, PETERSON, JOSEPH F. · 2018 to 2024
$8.2M
Integrated, Individualized, Intelligent Prescribing (I3P)U01HG007253 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LEVY, MIA A., PETERSON, JOSEPH F. · 2014 to 2018
$4.6M
NHGRI NIH HHS U01 HG007253NHGRI NIH HHS U01 HG010232
6 · The paper itself

Abstract

The prognostic value of nucleophosmin-1 (

Indexed as

acute myeloid leukemiaFLT3NMP1prognostic markers

Identifiers

PMID41332821
PMCPMC12668056

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.